GLP-1 drugsHuman trial
Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial
Lancet
The paper
Virginia Bellido, Carel Wynand le Roux, Elif I Ekinci, Amanda J. Taylor
Show 7 more authors
Petter Bjornstad, Juan P. Frías, Kathryn A. Giblin, Sarah Eyde, So Young Park, Joao Ferro, Caroline Johnson,Hospital Universitario Virgen del Rocío · Eli Lilly (United States)
Lancet · 29 Sep 2026